- Home
- EHAB vs BBNX Comparison
EHAB vs BBNX Comparison
Compare EHAB & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHAB
- BBNX
- Stock Information
- Founded
- EHAB 2014
- BBNX 2015
- Country
- EHAB United States
- BBNX United States
- Employees
- EHAB N/A
- BBNX N/A
- Industry
- EHAB Hospital/Nursing Management
- BBNX Medical/Dental Instruments
- Sector
- EHAB Health Care
- BBNX Health Care
- Exchange
- EHAB Nasdaq
- BBNX Nasdaq
- Market Cap
- EHAB 405.4M
- BBNX 463.4M
- IPO Year
- EHAB N/A
- BBNX 2025
- Fundamental
- Price
- EHAB $7.68
- BBNX $11.14
- Analyst Decision
- EHAB Hold
- BBNX Strong Buy
- Analyst Count
- EHAB 3
- BBNX 6
- Target Price
- EHAB $8.50
- BBNX $26.67
- AVG Volume (30 Days)
- EHAB 311.6K
- BBNX 690.5K
- Earning Date
- EHAB 05-07-2025
- BBNX 05-06-2025
- Dividend Yield
- EHAB N/A
- BBNX N/A
- EPS Growth
- EHAB N/A
- BBNX N/A
- EPS
- EHAB N/A
- BBNX N/A
- Revenue
- EHAB $1,034,800,000.00
- BBNX $65,123,999.00
- Revenue This Year
- EHAB $5.33
- BBNX $29.49
- Revenue Next Year
- EHAB $4.86
- BBNX $34.93
- P/E Ratio
- EHAB N/A
- BBNX N/A
- Revenue Growth
- EHAB N/A
- BBNX 442.93
- 52 Week Low
- EHAB $6.85
- BBNX $8.89
- 52 Week High
- EHAB $10.70
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- EHAB 34.58
- BBNX N/A
- Support Level
- EHAB $7.56
- BBNX N/A
- Resistance Level
- EHAB $7.91
- BBNX N/A
- Average True Range (ATR)
- EHAB 0.35
- BBNX 0.00
- MACD
- EHAB -0.08
- BBNX 0.00
- Stochastic Oscillator
- EHAB 9.42
- BBNX 0.00
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.